Results 11 to 20 of about 32,786 (201)

CURRENT ANALYTICAL METHODS FOR AMLODIPINE AND ITS FORMULATIONS: A REVIEW [PDF]

Journal CleanWAS, 2017
The use of amlodipine is very common due to the effects of amlodipine on hypertension and coronary artery disease (CAD) like chronic stable angina, vasospastic angina (Prinzmetal’s or variant angina), and angiographically documented CAD.
A.b. M. Helal , Mohamed , Zaidul , S.A., Mohamed, Fahim   +5 more
doaj   +1 more source

CONTEMPORARY SIGHT AT AMLODIPINE AND NEW DRUGS OF S-AMLODIPINE

Рациональная фармакотерапия в кардиологии, 2016
Contemporary scientific data about mode of action of calcium channel blocker — amlodipine, its pleiotropic effect (influence on endothelial function and antiatherogenic action) is presented.
M. V. Leonova
doaj   +1 more source

Modern views on amlodipine and new S-amlodipine medications

Кардиоваскулярная терапия и профилактика, 2011
The review presents the latest evidence on the calcium antagonist amlodipine, summarizing its mechanisms of action, its pleiotropic, endothelial function-related effects, and its anti-atherogenic activity.
M. V. Leonova
doaj   +1 more source

Association of Amlodipine with the Risk of In-Hospital Death in Patients with COVID-19 and Hypertension: A Reanalysis on 184 COVID-19 Patients with Hypertension

Pharmaceuticals, 2022
Association between calcium channel blockers (CCBs) or functional inhibitors of acid sphingomyelinase (FIASMAs) use and decreased mortality in people with COVID-19 has been reported in recent studies.
Gwenolé Loas, Philippe Van de Borne, Gil Darquennes, Pascal Le Corre   +3 more
doaj   +1 more source

Amlodipine gynaecomastia

The Breast, 2001
We report only the second published confirmed case of gynaecomastia caused by amlodipine (a dihydropyridine calcium channel blocker). Gynaecomastia developed in a 70-year-old male within 3 months of starting amlodipine, and symptoms resolved within 3 weeks of drug withdrawal suggesting a strong relationship between amlodipine and gynaecomastia in this ...
P G, Cornes, A C, Hole
openaire   +2 more sources

Bioequivalence study of fixed-dose combination Losartan + amlodipine + rosuvastatin Sanofi in comparison with coadministered fixed- dose combination Lozap® AM and monocomponent drug Crestor® in healthy subjects

Фармакокинетика и Фармакодинамика, 2022
Introduction. The advantages of fixed-dose combination losartan + amlodipine + rosuvastatin compared to mono-drugs and two-component combinations are to increase the therapeutic efficacy, to reduce the cost of the product and to make the drug easier to ...
A. L. Khokhlov, D. Yu. Grebenkin, E. K. Faeva, V. I. Kazey, A. A. Khokhlov, A. E. Miroshnikov, O. V. Lebedeva   +6 more
doaj   +1 more source

THE ROLE OF S-AMLODIPINE IN ARTERIAL HYPERTENSION THERAPY WITH COMBINATION OF CALCIUM CHANNEL BLOCKERS AND BETA-BLOCKERS

Рациональная фармакотерапия в кардиологии, 2015
Aim. To study efficacy and safety of calcium channel blocker, S-amlodipine, in combination with β-blocker, atenolol, in patients with arterial hypertension (HT) 1-2 degree com- pared to fixed combination of racemic amlodipine and atenolol.Material and ...
M. A. Maksimova, Yu. V. Lukina, S. Yu. Martsevich   +2 more
doaj   +3 more sources

Synergism of amlodipine and telmisartan or candesartan on blood pressure reduction by using SynergyFinder 3.0 and probability sum test in vivo

Pharmacology Research & Perspectives, 2023
This study was designed to evaluate the synergism of two couples of antihypertensive drugs (amlodipine + telmisartan and amlodipine + candesartan) on blood pressure reduction in vivo by both SynergyFinder 3.0 and probability sum test.
Tian Xia, Lu‐Lu Xu, Peng‐Yue Guo, Wan‐Ting Shi, Yan‐Qiong Cheng, Ai‐Jun Liu   +5 more
doaj   +1 more source

COMPARATIVE STUDY OF EFFICIENCY AND SAFETY OF THE NEW DRUG OF AMLODOPINE – S-AMLODOPINE IN PATIENTS WITH ARTERIAL HYPERTENSION OF I-II DEGREE

Рациональная фармакотерапия в кардиологии, 2016
Aim. To evaluate efficacy and safety of a new drug of amlodipine – S-amlodipine (Azomex, Emcur, India) compared to original drug of racemic amlodipine (Norvasc, Pfizer, USA) in patients with arterial hypertension (HT) of I-II grade.Material and methods ...
M. A. Maksimova, Y. V. Lukina, S. N. Tolpygina, E. V. Shilova, N. A. Dmitrieva, S. Y. Martsevich   +5 more
doaj   +1 more source

Impact of Cumin and Green Tea on Amlodipine Pharmacodynamics and Pharmacokinetics in Hypertensive Rats

Separations, 2023
The main purpose of the current research was to determine the impact of cumin and green tea on the pharmacodynamics and pharmacokinetics of amlodipine in hypertensive rats. Wistar rats were given 40 mg/kg of L-NAME orally every day for two weeks in order
Ibrahim Abdelsalam Abdelrahman, Abdul Ahad, Mohammad Raish, Yousef A. Bin Jardan, Mohd Aftab Alam, Fahad I. Al-Jenoobi   +5 more
doaj   +1 more source